Pre-market hot trades in US stocks: Microchip Tech fell 3.02% in pre-market, Wells Fargo lowered its target price

Microchip Tech pre-market down 3.02%; Lakewood-Amedex Biotherapeutics pre-market up 226.88%; Inlif pre-market up 61.43%; Core AI pre-market up 48.40%

Pre-market Hot Trades in US Stocks

Microchip Technology is down 3.02% in pre-market trading. Based on recent news,

On July 21, Wells Fargo lowered the target price for Microchip Technology from $95 to $88, maintaining a "hold" rating. This move reflects market concerns about the company's future profitability, leading to a decline in stock price.
On July 20, Wells Fargo reaffirmed the target price cut for Microchip Technology and noted that the company does not have an advantage on the analyst recommended stock list, further undermining investor confidence.
On July 19, BofA's equity derivatives team pointed out that Microchip Technology has some premium income and upside potential in the Russell 1000 index, but overall market sentiment is leaning neutral to mildly bullish, failing to effectively boost the stock price. Market sentiment is neutral, with a focus on macroeconomic data.

Top Gainers in Pre-market US Stocks

Lakewood-Amedex is up 226.88% in pre-market trading. Based on recent key news:

On July 22, Lakewood-Amedex released new resistance data for its Nu-3 drug. Nu-3 did not show induced resistance in continuous passage studies, supporting its membrane disruption mechanism and playing an important role in antibiotic resistance development. This news significantly boosted the stock price. Source: PR Newswire
On July 22, the company issued a statement emphasizing the risks and uncertainties that clinical trials may face, including the possibility that trials may not start, complete, or succeed as expected. These risk factors may affect investor confidence. Source: Company announcement
No other significant news recently. The biotechnology sector has been active lately, with noticeable capital inflows.

Inlif is up 61.43% in pre-market trading, with no significant news recently. Trading is active, with clear capital flows; considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.

Core AI is up 48.40% in pre-market trading. Based on recent key news:

On July 21, Core AI announced the expansion of its AI strategy, launching a multimodal home design and renovation visualization tool. This strategic move aims to enhance the company's service capabilities and solidify its position in the industry. This involves significant investment and is expected to significantly expand the company's market coverage.
On July 21, Core AI's technical sentiment signal indicated a sell, although the very low price-to-earnings ratio provides some valuation support, it is not enough to offset financial and trend risks.
On July 21, Core AI detailed several risk factors in its annual report, including market conditions, customer demand, and supply chain status, which could lead to significant differences between actual results and expectations. Innovation in the AI industry is accelerating, and market volatility is increasing

Pre-market Hot Trades in US Stocks

Microchip Technology is down 3.02% in pre-market trading. Based on recent news,

On July 21, Wells Fargo lowered the target price for Microchip Technology from $95 to $88, maintaining a "hold" rating. This move reflects market concerns about the company's future profitability, leading to a decline in stock price.
On July 20, Wells Fargo reaffirmed the target price cut for Microchip Technology and noted that the company does not have an advantage on the analyst recommended stock list, further undermining investor confidence.
On July 19, BofA's equity derivatives team pointed out that Microchip Technology has some premium income and upside potential in the Russell 1000 index, but overall market sentiment is leaning neutral to mildly bullish, failing to effectively boost the stock price. Market sentiment is neutral, with a focus on macroeconomic data.

Top Gainers in Pre-market US Stocks

Lakewood-Amedex is up 226.88% in pre-market trading. Based on recent key news:

On July 22, Lakewood-Amedex released new resistance data for its Nu-3 drug. Nu-3 did not show induced resistance in continuous passage studies, supporting its membrane disruption mechanism and playing an important role in antibiotic resistance development. This news significantly boosted the stock price. Source: PR Newswire
On July 22, the company issued a statement emphasizing the risks and uncertainties that clinical trials may face, including the possibility that trials may not start, complete, or succeed as expected. These risk factors may affect investor confidence. Source: Company announcement
No other significant news recently. The biotechnology sector has been active lately, with noticeable capital inflows.

Core AI is up 48.40% in pre-market trading. Based on recent key news:

On July 21, Core AI announced the expansion of its AI strategy, launching a multimodal home design and renovation visualization tool. This strategic move aims to enhance the company's service capabilities and solidify its position in the industry. This involves significant investment and is expected to significantly expand the company's market coverage.
On July 21, Core AI's technical sentiment signal indicated a sell, although the very low price-to-earnings ratio provides some valuation support, it is not enough to offset financial and trend risks.
On July 21, Core AI detailed several risk factors in its annual report, including market conditions, customer demand, and supply chain status, which could lead to significant differences between actual results and expectations. Innovation in the AI industry is accelerating, and market volatility is increasing